Myelodysplastic Syndrome

Which criteria determine a high response to immune stimulation therapy for low risk MDS? Age less than 60/PNH positive clone/STAT3 mutant T-cell clone/ hypocellular bone marrow/maximum 5% blasts in the bone marrow

en_USEnglish